AskVantage

Commure

Commure is a health AI company based in Mountain View, United States, founded in 2017. AI platform for healthcare revenue cycle and documentation. It was valued at $7bn on 19 May 2026 (Growth financing ($70m)), which makes it a unicorn in the 311 Unicorn Index.

Part of the 311 Unicorn Index (311institute.com). Last updated .

$7bnValuation
19 May 2026As of
Mountain View, United StatesHeadquarters
2017Founded
Health AISector
Unicorn311 status
Book a Briefing
$7bn ยท Growth financing ($70m)
Source: Company announcement (also Reuters)

About Commure

AI platform for healthcare revenue cycle and documentation. Lead investors in its latest round: General Catalyst. Website: commure.com.

How this figure is calculated

The valuation set by the latest priced funding round or company-run share sale, as announced by the company or its lead investor, or reported by a major news organisation. Figures in other currencies are converted at the rate on the day of the round. Talks that have been reported but not closed do not count.

Related

Other unicorns in United States

Questions and answers

How much is Commure worth?

Commure was valued at $7bn on 19 May 2026 (Growth financing ($70m)), according to the 311 Unicorn Index.

Where is Commure based?

Commure is headquartered in Mountain View, United States.

When was Commure founded?

Commure was founded in 2017.

What does Commure do?

AI platform for healthcare revenue cycle and documentation.

Is Commure a unicorn?

Yes. Commure is a privately held company valued at $1 billion or more, so it is a unicorn in the 311 Unicorn Index.

© 311 Institute 2026. Facts from the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.